ConductScience.org, home

Paper1100296

Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.

Paulson GW and 2 others. Clin Pediatr (Phila), 1975. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines. Papers, record 1100296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1100296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
PubMed
Journal
Clin Pediatr (Phila)
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
3.08
iCite
Revised in PubMed
2017-02-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Paulson GWG W
2Rizvi CAC A
3Crane GEG E

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Movement DisordersMajor topic
PhenothiazinesMajor topic
Adolescent
Child
Chlorpromazine
Clinical Trials as Topic
Diagnosis, Differential
Dystonia Musculorum Deformans
Female
Hospitalization
Hospitals, Psychiatric
Humans
Intellectual Disability
Male
Parkinson Disease
Thioridazine
Trifluoperazine

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
38862692Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review.Drug Saf2024https://conductscience.org/library/papers/38862692PubMed
29484607Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.Drugs2018https://conductscience.org/library/papers/29484607PubMed
29409162Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29409162PubMed
16648965Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.Eur Child Adolesc Psychiatry2006https://conductscience.org/library/papers/16648965PubMed
8819877Tardive dyskinesia and pregnancy and delivery complications.Child Psychiatry Hum Dev1996https://conductscience.org/library/papers/8819877PubMed
202447Environmental effects on the central nervous system.Environ Health Perspect1977https://conductscience.org/library/papers/202447PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1100296

GET https://conductscience.org/api/papers/v1/1100296/authors